148 related articles for article (PubMed ID: 2462946)
41. Immunotherapy of renal cell carcinoma.
deKernion JB
Prog Clin Biol Res; 1984; 153():409-21. PubMed ID: 6206509
[TBL] [Abstract][Full Text] [Related]
42. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
43. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
44. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
45. Interferons in the therapy of solid tumors.
Agarwala SS; Kirkwood JM
Oncology; 1994; 51(2):129-36. PubMed ID: 7515168
[TBL] [Abstract][Full Text] [Related]
46. Interferons: present and future use in cancer therapy.
Golomb HM
J Clin Oncol; 1986 Feb; 4(2):123-5. PubMed ID: 2418165
[No Abstract] [Full Text] [Related]
47. Role of interferon in clinical practice.
Sréter L; Fehér J
Ther Hung; 1991; 39(4):159-66. PubMed ID: 1725832
[TBL] [Abstract][Full Text] [Related]
48. Perusing the ASCO abstracts with a focus on interferons in malignant melanoma and renal cell carcinoma.
Carter SK
Cancer Chemother Pharmacol; 1984; 13(3):153-6. PubMed ID: 6207947
[No Abstract] [Full Text] [Related]
49. Human leukocyte interferon in therapy of patients with urinary bladder papillomatosis, breast cancer, and melanoma.
Maricić Z; Nola P; Ikić D; Smudj K; Oresić V; Knezević M; Rode B; Jusić D; Soos E
J Cancer Res Clin Oncol; 1981; 101(3):317-23. PubMed ID: 6171574
[TBL] [Abstract][Full Text] [Related]
50. An assessment of the current use of human interferons in therapy of urological cancers.
Horoszewicz JS; Murphy GP
J Urol; 1989 Nov; 142(5):1173-80. PubMed ID: 2478725
[No Abstract] [Full Text] [Related]
51. Interferon: a new name in cancer treatment.
Lancaster J
Nurs RSA; 1987 Feb; 2(2):28-9. PubMed ID: 2438555
[No Abstract] [Full Text] [Related]
52. [Phase I-II studies on various types of interferon against malignant tumors].
Mitachi Y; Kambe M; Asamura M; Wakui A
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):33-42. PubMed ID: 2454276
[No Abstract] [Full Text] [Related]
53. Application of human leucocyte interferon in patients with urinary bladder papillomatosis, breast cancer, and melanoma.
Ikić D; Nola P; Maricić Z; Smudj K; Oresić V; Knezević M; Rode B; Jusić D; Soos E
Lancet; 1981 May; 1(8228):1022-4. PubMed ID: 6164883
[TBL] [Abstract][Full Text] [Related]
54. [Interferons in medicine].
Lucivero G
Recenti Prog Med; 1990 May; 81(5):329-36. PubMed ID: 1696020
[TBL] [Abstract][Full Text] [Related]
55. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery.
MacKie RM; Reid R; Junor B
N Engl J Med; 2003 Feb; 348(6):567-8. PubMed ID: 12571271
[No Abstract] [Full Text] [Related]
56. Sensitivity of breast and ovarian cancer cells for interferons (IFNs) and retinoids.
Daxenbichler G; Widschwendter M; Marth C
Ann N Y Acad Sci; 1996 Apr; 784():294-303. PubMed ID: 8651578
[No Abstract] [Full Text] [Related]
57. [Expectations in the clinical application of human-recombinant cytokines. 1) Present status of clinical application of interferons].
Taguchi T
Nihon Rinsho; 1988 May; 46(5):1085-92. PubMed ID: 2457721
[No Abstract] [Full Text] [Related]
58. The use of immunized pig lymph-node cells in the treatment of patients with advanced malignant disease.
Symes MO; Riddell AG
Br J Surg; 1973 Mar; 60(3):176-80. PubMed ID: 4735046
[No Abstract] [Full Text] [Related]
59. Interferons: pleiotropic cellular modulators.
Borden EC
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S18-24. PubMed ID: 1370263
[TBL] [Abstract][Full Text] [Related]
60. Interferon treatment of human malignancies--a short review.
Einhorn S; Strander H
Med Oncol Tumor Pharmacother; 1993; 10(1-2):25-9. PubMed ID: 7505041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
